PharMerica Corporation (PharMerica), a provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, has amended its existing credit agreement with Bank of America to increase the company’s borrowing capacity by roughly $150 million.
Under the terms of the amended credit agreement, the revolving facility increased by $60 million and the term loan facility increased by approximately $90 million.
The amended credit agreement also increased the accordion feature, which now provides PharMerica with an incremental basket of up to $200 million.
“This expansion of our borrowing capacity will give PharMerica the financial flexibility to drive further business diversification and value-enhancing growth in 2017. We appreciate the strong support of our lenders and their continued confidence in PharMerica,” said Greg Weishar, CEO of PharMerica.
PharMerica, US, Healthcare, Risk management, Pharmacy, Bank of America, Greg Weishar